( December 4, 2025, 11:02 AM EST) -- Bristol Myers Squibb Co. (BMS) and Sanofi-Aventis US LLC responded to a complaint filed by Texas alleging that the pharmaceutical companies violated state law by falsely marketing the antiplatelet drug Plavix as effective without disclosing a genetic contraindication by petitioning another state court for declaratory and injunctive relief....